Evaluation of the safety of amantadine-HCl and the role of respiratory viral infections in children with cystic fibrosis.
primary studies published RCT
Details- 1976
- Wright PF
Influence of mist tent therapy on sputum viscosity and water content in cystic fibrosis.
primary studies published RCT
Details- 1974
- Rosenbluth M
Assessment of medium-chain triglyceride feeding in infants with cystic fibrosis.
primary studies published RCT
Details- 1969
- Gracey M
A double-blind study of the use of acetylcysteine in patients with cystic fibrosis.
primary studies published RCT
Details- 1966
- Howatt WF
Studies of tocopherol deficiency in infants and children: VI. Evaluation of muscle strength and effect of tocopherol administration in children with cystic fibrosis.
primary studies published RCT
Details- 1961
- Levin S
Non-invasive evaluation of steatosis and fibrosis in the liver in adults patients living with cystic fibrosis.
primary studies published, non RCT
Details- 2025
- Piñar-Gutiérrez A
Long-term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real-world cohort study.
primary studies published, non RCT
Details- 2026
- Perrotta N
Impact of elexacaftor/tezacaftor/ivacaftor on gastrointestinal outcomes, inflammation, exocrine pancreatic function and fat malabsorption: Report of PROMISE pediatric substudy.
primary studies published, non RCT
Details- 2026
- Green N
Advancing Cystic Fibrosis-Related Diabetes Care With Automated Insulin Delivery Systems.
primary studies published, non RCT
Details- 2026
- Grancini V
Persistence of lung hyperinflation and small airway dysfunction in school-aged children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: results from the real-world MODUL-CF study.
primary studies published, non RCT
Details- 2026
- Colin L